Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
IST:ICUGS's EV-to-EBITDA is ranked worse than 100% of 510
companies
in the Asset Management industry
Industry Median: 8.53
vs IST:ICUGS: -358.13
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
ICU Girisim Sermayesi Yatirim Ortakligi AS (IST:ICUGS) EV-to-EBITDA Explanation
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
ICU Girisim Sermayesi Yatirim Ortakligi AS's PE Ratio (TTM) for today is calculated as:
ICU Girisim Sermayesi Yatirim Ortakligi AS's share price for today is ₺5.40.
ICU Girisim Sermayesi Yatirim Ortakligi AS's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₺-0.060.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ICU Girisim Sermayesi Yatirim Ortakligi AS EV-to-EBITDA Chart
ICU Girisim Sermayesi Yatirim Ortakligi AS Annual Data
IST:ICUGS vs BLK, BX, KKR: EV-to-EBITDA Comparison
For the Asset Management subindustry, ICU Girisim Sermayesi Yatirim Ortakligi AS's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
ICU Girisim Sermayesi Yatirim Ortakligi AS EV-to-EBITDA vs Asset Management Industry
ICU Girisim Sermayesi Yatirim Ortakligi AS's current Enterprise Value is ₺1,909.87 Mil.
ICU Girisim Sermayesi Yatirim Ortakligi AS's EBITDA for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₺-5.33 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ICU Girisim Sermayesi Yatirim Ortakligi AS (IST:ICUGS) has a EV-to-EBITDA of -358.12 as of Aug. 12, 2026. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on ICU Girisim Sermayesi Yatirim Ortakligi AS. According to the industry distribution chart, ICU Girisim Sermayesi Yatirim Ortakligi AS ranks #999999 out of 510 companies in the Asset Management industry.
Is ICU Girisim Sermayesi Yatirim Ortakligi AS's EV-to-EBITDA too high?
ICU Girisim Sermayesi Yatirim Ortakligi AS's current EV-to-EBITDA is -358.12. Based on the distribution chart, ICU Girisim Sermayesi Yatirim Ortakligi AS ranks #999999 out of 510 companies in the Asset Management industry, which is in the bottom quartile relative to peers. Overall, ICU Girisim Sermayesi Yatirim Ortakligi AS has a GF Score™ of 15/100, reflecting its overall financial health beyond just this single metric.
How does ICU Girisim Sermayesi Yatirim Ortakligi AS's EV-to-EBITDA compare to BLK and BX?
According to the Asset Management industry distribution chart, ICU Girisim Sermayesi Yatirim Ortakligi AS ranks #999999 out of 510 companies for EV-to-EBITDA. This places ICU Girisim Sermayesi Yatirim Ortakligi AS in the lower half of its industry. The industry median EV-to-EBITDA is 8.53. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBITDA for an Asset Management company?
The median EV-to-EBITDA among Asset Management companies is 8.53, based on 510 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBITDA mean?
A high EV-to-EBITDA can signal that a stock is expensive relative to its fundamentals. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on ICU Girisim Sermayesi Yatirim Ortakligi AS. For the Asset Management industry, the median EV-to-EBITDA is 8.53 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. ICU Girisim Sermayesi Yatirim Ortakligi AS's current EV-to-EBITDA is -358.12. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is ICU Girisim Sermayesi Yatirim Ortakligi AS stock overvalued right now?
ICU Girisim Sermayesi Yatirim Ortakligi AS (IST:ICUGS) has a current EV-to-EBITDA of -358.12. The current EV-to-EBITDA is -358.12. ICU Girisim Sermayesi Yatirim Ortakligi AS's overall GF Score™ is 15/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBITDA calculated?
EV-to-EBITDA is calculated from a company's financial statements. For ICU Girisim Sermayesi Yatirim Ortakligi AS (IST:ICUGS), the current EV-to-EBITDA is -358.12 as of Aug. 12, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
ICU Girisim Sermayesi Yatirim Ortakligi AS is a Turkey based investment banking company. It operates as a venture capital company. The company invests in portfolio of companies which includes OEP RHEA Turkey Tech, Seta Medical, Netsafe Information System, and RML Lines.
15GF Score
Get the complete analysis for IST:ICUGS
EV-to-EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
IST:ICUGS has been successfully added to your 
